Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...

Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...

Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...

Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court ...

Americans are at risk of cardiovascular disease. Bayer aspirin is on a mission to combat the high statistics of people who ...

Did you know, that in a study of those who experienced a heart attack at age 50 or younger, half were not previously seen as ...

Their relegation six-pointer against Holstein Kiel resulted in an emphatic 3-1 win that lifted them off the bottom of the table and put Holstein there in their place. Every team in the bottom three ...

Matchday 26 in the Bundesliga saw last-minute comebacks, relegation six-pointers, and the push for Europe get so tight that ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Led by Singapore, a 12-year, international, multi-centre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer in over 1,500 patients has been completed and published in ...